Contemporary OB/GYN week in review: the impact of stillbirths, discussing hernia repair, and more
Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
Contemporary OB/GYN week in review: the impact of stillbirths, discussing hernia repair, and more
Thank you for visiting the Contemporary OB/GYN® website. Take a look at some of our top stories from last week (Monday, September 3 - Friday, September 8, 2023), and click each link to read and watch anything you may have missed.
1.) The impact of stillbirths on patients and providers
Stillbirths are one of the most tragic situations for obstetrician-gynecologists to encounter, making awareness vital.
Click here for the full article.
2.) Discussing hernia repair in obstetrics
In a recent article, authors discussed approaches obstetricians and gynecologists should take in hernia repair based on a patient’s risk status.
Click here for the full article.
3.) How to have difficult discussions
What are the key factors of communication with a patient who is fearing symptom progression or near death?
Click here for the full article.
4.) Parents’ stigmatizing beliefs about HPV vaccine
A recent study found children may be more hesitant to seek vaccination for human papillomavirus if their parents hold stigmatizing beliefs.
Click here for the full article.
5.) Risk-reducing bilateral salpingo-oophorectomy adherence differs by provider
In a recent study, increased rates of risk-reducing bilateral salpingo-oophorectomy guideline adherence was observed in gynecologic oncologists compared to general gynecologists.
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Nipocalimab shows promise in preventing hemolytic disease of the fetus and newborn
August 21st 2024The investigational drug could prevent the rare fetal disease HDFN (hemolytic disease of the fetus and newborn) by stopping harmful antibodies from transferring through the placenta during pregnancy.
Read More
